Log in

Your Resource for Neurotherapeutics Discovery and Development

  • Home
  • Annual Meeting

Annual Meeting Overview


Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2025) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 12-14, 2025. 

ASENT's 2025 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features nine symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

2025 Meeting Highlights 

    • 12 - 16 Scientific Symposia featuring Neuroscience leaders from Industry, Academia, FDA, NIH, and Advocacy
    • LATEST DATA: Covid CNS Update
    • DEBATE: Featuring a hot topic and current data
    • CNS PIPELINE Presentations
    • CAREER DINNER Featuring Guest Speakers
    • NEUROTHERAPEUTICS DINNER Featuring Guest Speakers
    • Interactive Poster Discussions
    • Sponsored Symposia from Innovation Leaders
    • Live Discussions in Breakout Rooms with Speakers
    • 2nd Annual Neurotherapeutics Clinical Trial Course - LIVE  (application only)

    Popular Sessions from 2024 Meeting 

    • FIRESIDE CHAT: Preclinical to First in Human in Neurotherapeutic Drug Development
    • Platform Clinical Trials in Neurology Featuring speakers from FDA and Biohaven
    • Exosome in Neurotherapeutics
    • Digital Biomarkers in CNS Clinical Studies
    • Opportunities to streamline development of gene therapies for rare diseases featuring speakers from FDA and Eli Lilly
    • Current research and Advances in Multiple Sclerosis
    • Parkinson's disease biological staging and implications for therapeutic trials
    • Fluid Biomarkers as endpoints for neurodegenerative diseases
    • Animal Models in Neurotherapeutics: the good, the bad and the ugly.
    • Novel Delivery Systems in CNS

    Meeting Location
    Hyatt Regency Bethesda, Bethesda MD


    Who Attends

    50% of attendees are practicing physicians| Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2025 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at a discounted cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 

    Upcoming events

    No events available

    Powered by Wild Apricot Membership Software